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Production, characterization and nephritogenicity of a mofloclonal
antibody against glomerular basement membrane heparan sulfate. J. van
den Born, L.P. W.J. van den Heuve!, M.A.H. Bakker, J.H. Veerkamp,
KJ.M. Assmann, J.H.M. Berden, Departments of Nephrology, Biochem-
istry and Pathology, University of Nzjmegen, NUmegen, The Netherlands,
To study the role of heparan sulfate (HS) in the permselective properties
of the glomerular basement membrane (GBM), monoclonal antibodies
(mAB) against HS can be an important tool. For the production of these
mAB, heparan sulfate proteoglycan (HSPG) was partially purified from rat
glomeruli by extraction with 4 M guanidine HCI, dialysis against 7 M urea
and ion exchange chromatography. After immunization of mice, fusion
was carried out and a mAb, JM-403, with the following characteristics was
obtained. In ELISA, mAb JM-403 was strongly reactive with HS, and
could be inhibited in a dose-dependent manner by HS and heparin but not
by chondroitin sulfate or dermatan sulfate. In indirect immunofluores-
cence on cryostat sections of rat kidneys, a strong fine granular-to-linear
staining of the GBM was observed, along with staining of Bowman's
capsule, tubular basement membranes (TBM), basement membranes of
peritubular capillaries and smooth muscle cells in arterial walls. After
pre-incubation of the sections with 1 U/mI heparitinase all staining disap-
peared. These results indicate that mAb JM-403 is directed against the
HS-side chain of basement membrane HSPG. After i.v. injection into rats,
at 1 hour mAb JM-403 was detected along the glomerular capillary wall in
a fine granular pattern, which shifted towards a more mesangial localiza-
tion after 24 hours; at day IS no binding was observed. A single i.v.
injection of 500 mAb into rats (N = 6) induced albuminuria, which was
maximally at day 1 (mean six 2523 1990 tg/24 hr compared to 85
41 sg/24 hr in control animals; P < 0.03) and declined gradually to control
values at day 8. This mAb enables us to study in more detail the impact of
antibody binding to HS-associated anionic sites in the GBM on glomerular
permselectivity. Moreover, since mAb JM-403 is cross reactive with
human HS, it can be used to study the HS-content of glomeruli in various
human glomerulopathies.
Involvement of endothelial non-MHC (allo)antigens in antibody-medi-
ated chronic renal allograft rejection. A. Duijvestyn, L. VIek, E. Duis-
termaat, P. van Breda Vriesman, Department of Immunology, Univer-
sity of Limburg, Maastricht, The Netherlands. To study mechanisms in
chronic renal allograft rejection in the absence of iatrogenic immuno-
suppression, we set up an experimental rat transplantation model in
which BN host were made tolerant of donor Lewis erythrocytes
(LEW-E) before receiving a Lewis kidney. Such BN hosts accept LEW
kidneys for over 50 days in the absence of anti-LEW erythrocyte (class
1) alloantibodies. In this setting, Lewis renal allografts are chronically
rejected with stable renal function (urea <200 mg/lOO ml) but increasing
proteinuria (>l00 mg/24 hr). Immunohistochemistry was applied on
kidney sections to study infiltrating cells, vascular endothelium, immu-
noglobulin deposition, MHC antigen expression and intravascular co-
agulation. Additionally, involvement of endothelial antigens was stud-
ied by measurement of serum antibody reactivity to Lewis and BN but
also Lew.IN (BN MHC) and BN.IL (Lewis MHC) heart endothelium.
The results show that, in Contrast to acutely rejected Lewis kidneys by
unmodified BN recipients, the grafts in chronic rejection had exclusive
glomerular (and arteriolar) but not peritubular capillary lesions associ-
ated with intravascular coagulation. Cellular infiltrate consisted of
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macrophages and predominantly T helper lymphocytes, suggesting
rejection was antibody rather than cellular mediated. Graft endothelium
was class II negative, in contrast to tubular epithelium. Whereas IgG
deposition was diffusely deposited in grafts, deposition of 1gM in
chronic rejection was, in contrast to acute rejection, exclusively depos-
ited along the glomerular and arteriolar vasculature. Serum antibody
reactivity was with graft, but not host, endothelium and antibody
specificity was defined for non-MHC Lewis endothelial (allo)antigens.
We conclude that in chronic renal graft rejection glomerular non-MHC
endothelial antigens are selectively involved in vascular rejection.
Plasma oncotic pressure (COl') is not a determinant of impaired sodium
excretion in nephrotic syndrome (NS). J.A. B,jlsma, A.J. Rabelink, H.A.
Koomans, Department of Nephrology, University Hospital Utrecht,
The Netherlands. According to classical theories, sodium (Na) reten-
tion in NS is mediated by lowered COP, which may cause a fluid shift
at the capillary level from the blood towards the interstitium, and
subsequently a decrease in effective circulating volume. Several obser-
vations speak against this hypovolemia theory, one being that during
the remission of a nephrotic episode the natriuresis precedes the rise in
plasma COP. Plasma renin activity (PRA) often decreases at the start of
remission. Although this supports the hypovolemia theory, it could also
indicate renal repair, normalizing renal sodium excretion and renin
production. We therefore studied concentrations of plasma ANP during
steroid induced remission in edematous patients with minimal lesions(N = 6), which may be regarded as a more neutral indicator of
circulating blood volume. Again, natriuresis took place before any
change in COP had occurred, and COP was still at very low values
(range 8-12 mm Hg). PRA fell in 3 patients prior to remission, but no
change in hernatocrit or plasma ANP was observed during remission. In
previous studies we found that infusion of hyperoncotic albumin has
little effect on sodium excretion in patients with NS. Although this
observation was interpreted to speak against the hypovolemia theory,
the sudden rise in plasma COP (plasma albumin rose from 15.3 to 21.7
g/liter) associated with this infusion may have prevented an increase in
sodium excretion. Therefore in a second study we infused iso-oncotic
albumin (individually adapted) to expand plasma volume —17% in I
hour in 8 edematous (surplus 7.8 1.2 kg) patients with NS. Renal
plasma flow increased from 653 72 to 791 91 mI/mm, filtration
fraction fell from 11.1 1.1 to 9.3 0.8%, whereas GFR remained
constant (72.3 9.9 vs. 72.3 8.0 mI/mm). Na-excretion increased
from 61.2 18.8 to 112.2 18.7 mol/min. This volume expansion was
subsequently maintained during 2 days (Table). During these days 821
61 ml albumin solution was infused per 24 hours (± l20 mmol Na/24
hi). Despite this expansion, the large extracellular volume surplus and
increase in plasma ANP. only a very modest Na excretion was
observed, which did not exceed the infused amount of Na.
Before
expansion
24 Hr
expansion
48 Hr
expansion
PV liters 3.54 0.28 4.20 0.29 4.16 0.32
COP mm Hg Il.7 0.9 11.9 0.9 12.3 0.9
ANPpmol/ 31.4 5.8 66.8 20.2 81.5 26.4
liter
Na-excr 70 20 105 15 115 11
mmol/24 hr
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In summary, I) natriuresis of remission of a nephrotic episode starts
independent of a rise in plasma COP or plasma ANP, and 2) iso-oncotic
expansion does not evoke massive natriuresis in edematous nephrotic
patients. These data underscore the role of primary renal sodium
retention in nephrotic edema.
The antiproteinuric effect of an angiotensin converting enzyme (ACE)
inhibitor compared to conventional antihypertensive treatment. H.J.
Kloke, J.F.M. Wetzels, F.Th.M. Huysmans, H.W. van Hamersvelt,
R.A.P. Koene, Department of Nephrology, University Hospital N9-
megen, The Netherlands. The antiproteinuric effect of ACE inhibitors has
been ascribed to a reduction of systemic blood pressure (BP) as well as to
a decrease of intraglomerular pressure. However, it is not well docu-
mented whether BP reduction by conventional antihypertensive drugs will
result in a reduction of unnary protein excretion rate (UPE) comparable to
ACE inhibition. Therefore, we studied in a randomized cross over design
the effects of benazepril (B, a new ACE inhibitor) and the combination
(M+C) of metoprolol (M) and chlorthalidone (C)) on BP, UPE, GFR
(inulin clearance), RPF (PAH clearance) and filtration fraction (FF).
Patients were treated during six weeks each with B (20mg o.d.) and M+C
(200 mg M/25 mg C o.d.). Treatment periods were preceded by wash out
periods of 4 weeks each. We studied eight patients (5 menl3 women, mean
age 42 years) with a proteinuria of more than 2 g/24 hr and biopsy-proven
glomerulonephritis. MAP amounted 106 4 mm Hg, endogenous creati-
nine clearance 76 10 mllmin and UPE 8.7 1.8 g124 hr (means 5EM).
Results at the end of the treatment periods are given in the Table.
B M+C
MAP mmHg
UPEg/24hr
GFR ml/min/1.73 m2
RPF ml/minli.73 m2
FF%
95±5
5.2 1.6
43 5
293 36
15±2
93±3
5.3 1.2
39 6a
247 3W'
16±1
P < 0.05 compared to B
At similar degrees of BP reduction UPE was comparable during
treatment with B and M+C. Besides BP reduction a decrease in glomer-
ular pressure by efferent artenolar vasodilation during B and a decrease in
GFR during M+C may have contributed to the reduction in UPE.
Angiotensin II (Ang H) infusion does not reverse the antiproteinuric
effect of ACE inhibition by lisinopril in man. J.E. Heeg. P.E. de Jong,
G.K. van der Hem, D. de Zeeuw, State University Hospital Groningen,
Groningen, The Netherlands. Angiotensin converting enzyme (ACE)
inhibitors are known to lower urinary protein excretion in man with
renal disease. This antiproteinuric effect has been attributed to the renal
hemodynamic effects of ACE inhibition, presumably resulting in a fall
in intraglomerular capillary pressure, due to the inhibition of systemic
Ang II production. Indeed, Ang II induces proteinuria in rats by
increasing glomerular filtration pressure, which can be reversed by
concomitant Ang 11-receptor blockade. We studied the effects of 5%,
10% and 20% Ang II pressor doses in comparison with placebo infusion
in 2-hour periods in six non-diabetic normotensive proteinuric patients.
This was done before and after proteinuria had been lowered from 7.5
1.9 to 2.7 0.6 g124 hr by three months lisinopril therapy. Changes
(mean sEM) on Ang II vs. placebo are given:
Ang II induced characteristic renal effects were: a dose related fall in
renal plasma flow and natriuresis, and a rise in blood pressure, renal
vascular resistance and filtration fraction. Although Ang II infusion
during lisinopril treatment abolished all the hemodynamic effects in-
duced by the ACE inhibitor, Ang 11 did not change urinary protein loss
before nor during lisinopril and did therefore not reverse the antipro-
teinuric effect of ACE inhibition. Thus, there is a dissociation between
the Ang 11-induced effects on renal hemodynamics and the effects on
proteinuria in man, in contrast to animal data. We conclude that the
antiproteinuric effect of ACE inhibition is not mediated by changes in
systemic Ang II levels nor by the associated renal hemodynamic
effects.
Murine host-versus-graft reaction as a model of auto-immune glomer-
ulonephritis. S. Florquin, E. de Heer, J.A. Brudn, D. Abramowicz, J-M.
Doutrelepont, M. Goldman, Ph.J. Hoedemaeker, University Hospital,
Leiden, The Netherlands, and Université Libre de Bruxelles, Belgium.
BALB/c mice neonatally injected with 10 (A/JxBALB/c)Fl spleen cells
develop an autoimmune syndrome with glomerular lesions. In this
study, we first analyzed the time course development of the renal
pathology. From week 2 to week 6, linear deposits of IgGl were
observed by direct immunofluorescence (IF) along the glomerular
basement membrane (GBM) together with mesangial deposits of IgG,
1gM and C3. At week 8, the IF for IgGI changed to a fine granular
pattern. lgG2a, 1gM and C3 were also seen along the GBM but to a
lesser degree than IgGI. By immuno-electronmicroscopy, the IgG
deposits were located linearly along the epithelial side of the GBM at
week 6. Later on, electron-dense deposits containing IgG were found in
subepithelial position, in association with retraction of the podocytes.
In addition, focal glomerulosclerosis containing fibronectin, laminin and
collagen IV was observed in 50% of the 12-week-old mice. Seventy
percent of the animals developed abnormal albuminuria that persisted
for at least 12 weeks (30 to J0,000 g/24 hr). From week 2 to week 12,
HVG mice displayed circulating antibodies (ABs) to autoantigens of the
GBM (laminin, type IV collagen, fibronectin) and of renal tubular
epithelial cells (gp9O, gp330). Most of these auto-ABs belonged to the
IgGI sublcass. In vitro, coculture experiments indicated that anti-GBM
ABs were produced by donor-type B cells after stimulation by host T
cells. We conclude that the HVG reaction in mice leads to the
production of nephritogenic ABs and the development of immune
complex glomerulonephritis complicated by glomeruloscierosis.
Antiproteinuric effects of N-desulfated/acetylated heparin in murine
SLE. J.H.M. Berden, R.M. Termaat, A.P.M. van Gompel, K.J.M.
Assmann, H.A.M. Verheul, G.W.K. van Dedem. Departments of
Nephrology and Pathology, University Hospital Nijmegen and Orga-
non International, Oss. Recently, it has been shown that treatment with
N-desulfatedlacetylated heparin (DSA-HEP), that lacks anticoagulant
activity, has a protective effect on proteinuria and progression of focal
sclerosis in rats with subtotal renal ablation (J Clin Invest 81: 69, 1988).
Furthermore, it was found that DSA-HEP inhibits adjuvant arthritis and
autoimmune encephalomyelitis (J Clin Invest 83: 752, 1989). We inves-
tigated the effects of DSA-HEP in a spontaneous model of SLE
glomerulonephritis in MRL/l mice. From the age of 8 weeks, mice were
treated once daily with 300 or 5 g heparin (HEP resp. L-HEP) or
N-desulfated/acetylated heparin (DSA-HEP resp. L-DSA-HEP) subcu-
taneously. Control animals received saline s.c. Each treatment group
consisted of 10 animals. Albuminuria and anti-DNA levels were mea-
sured after 12 weeks of treatment (Table).
ACEi Baseline 5% Ang II 10% Ang II 20% Ang 11
MAP no 91.8 2.8 —1.0 1.1 +2.2 1.3 +3.6 1.2
tam Hg yes 79.1 3.0 +2.1 0.6 +4.0 1.5 +7.9 1.3
FF% no
yes
19.0 1.5
15.7 1.2
+0.8 0.5
+2.6 0.8
+1.5
+4.4
0.5
0.4
+3.4 1.2
+5.8 0.4
UNa no 3.9 0.9 —0.2 0.8 —2.0 0.9 —2.6 0.9
mmoll yes 3.0 0.9 +1.9 1.1 —1.5 1.9 —3.9 1.9
2 hr
UprOL no 0.52 0.12 +0.04 0.07 +0.01 0.06 —0.07 0.04
g/2 hr yes 0.12 0.02 —0.01 0.01 —0.04 0.04 —0.06 0.04
Treatment
Albuminuria
p.g/18 hr
Anti-DNA
U/mI DTH ratio
Saline 1104 677 2918 665 1.59 0.04
HEP 545 305 890 354 1.24 0.05a
L-HEP 101 6.la 891 244 1.64 0.05
DSA-HEP 308 122 2422 511 1.28 0.03
L-DSA-HEP 106 28 1276 380 1.72 0.02
Data are given as mean SEM
a P < 0.05 compared to saline
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Albuminuria was significantly reduced to levels just above the upper
limit of physiological albuminuria (100 sg/l8 hr), by treatment with low
doses of HE? or DSA-HEP. The severity of the glomerular lesions as
assessed by light microscopy and immunofluorescence was, however,
not altered by any of the treatments. Anti-DNA titers were significantly
reduced by both HEP-dosages, while only low doses DSA-HEP led to
a reduction (P = 0.07 vs. saline). This reduction in anti-DNA titers
suggests that HEP and DSA-HEP may exert immunosuppressive ef-
fects. High doses (300 g) of HE? or DSA-HEP, but not low doses (5
g) also reduced significantly the T cell mediated, delayed type hyper-
sensitivity (DHT) against BSA (Table). These preliminary results
indicate that high doses of HEP and DSA-HEP have immunosuppres-
sive properties in vivo. The antiproteinuric effect does not seem to be
due to this immunosuppressive effect, since low doses of HEP and
DSA-HEP, that did not show prominent immunosuppressive activity,
inhibited proteinuna, not withstanding an unchanged inflammatory
response in the glomeruli.
Deposition of IgA is associated with macrophage influx in the kidney of
rats. R.K. Stad, W.M.J.M. Rogers, V. Muizert, L.A. van Es, M.R.
Daha, Department of Nephrology, University Hospital Leiden, Leiden,
The Netherlands. The hallmark of primary IgA glomerulonephritis
(IgAGN) is the finding of mesangial IgA deposition in the kidney. This
IgA is presumably of dimeric or polymeric origin. In the present study
we have treated rats with dimethylnitrosamine (DMN) or D-galac-
tosamine (GALN) to achieve increased circulating IgA levels in rats.
GALN treated rats showed a sixfold increase in IgA levels after the first
intraperitoneal (i.p.) injection, whereas there was a tenfold increase
after a second i.p. injection. DMN treated rats showed a threefold
increase in IgA levels. No differences were observed in lgG or 1gM
levels between treated and non-treated rats. Sequential renal biopsies
analyzed by immunofluorescence exhibited mesangial deposits of IgA
with different intensities of C3 deposition. Rats treated with GALN
showed more IgA deposition in the kidney than DMN treated rats. The
deposition of C3 together with IgA was associated with an influx of
monocytes as detected by ED-I, an antibody directed against a rat
monocyte marker. These studies provide evidence that an increase in
serum IgA levels results in deposition of IgA in the kidney and that lgA
has an inflammatory potential.
A comparison of various techniques to measure renal function and
renal function reserve. H.J.G. Bib, J.F.M. Weizels, A.J.M. Donker,
University Hospital, N,jmegen and Free University Hospital, A,nster-
dam, The Netherlands. To compare various techniques to measure
renal function, GFR was tested both fasting at 210 mm (BL) and after a
meat meal at 330, 390 and 450 mm (M = 750 g stewed meat) in 8 healthy
volunteers. As measure of GFR we compared the '251-iothalamate
clearance ('2510T-U*V/P), the inulin clearance (l-U*V/P), both admin-
istered by continuous infusion, and the creatinine clearance (Car), with
Cr measured both enzymatically (E-Cr) and with Jaffé (i-Cr). Serum
E-Cr rose from BL = 70 4 to M = 177 19 smol/liter and serum i-Cr
from BL = 80 6 to M = 171 20 mol/liter. Results of renal function
measurement are shown in the Table.
BL (210 M (390
Clearances mm) mm) %
'2510T 132 20 148 12
lU*V/P 125 20 138 13
E-C, 148 24 172 14
J-C. 140 21 177 14
(mI/mm; mean SD, paired two-tailed Wilcoxon)
'2510T and l-U*V/P clearances proved to be well comparable (r
0.962), despite a small but significant difference (6.0 4.1%. P <0.01).
After the meat meal a comparable rise of '2510T and l-U*V/P was
found. ECr and JCr were higher both at BL and M. We conclude
that serum Cr can vary greatly after a meat meal. Cr calculations
overestimate GFR markedly. Both '25lOT clearance and inulin clear-
ance calculated by U*V/P well reflect the glomerular filtration rate.
99mTCMAG3 clearance as a parameter of effective renal plasma flow.
R.A.M. Kengen, S. Meijer, D.A. Piers, University Hospital, Gronin-
gen, The Netherlands. 99"Tc-MAG3 (MAG3) is more and more becom-
ing the main radiopharmaceutical for renography studies because of
favorable practical aspects and superior image quality of the studies. So
far, no significant differences have been found between the renogram
curves and left/right kidney function determinations of MAG3 and
hippurate studies (l23 or '311-hippurate). Although the clearance of
MAG3 is only about 60% of the hippurate clearance, excellent corre-
lation between the two was found, making ERPF measurements with
MAG3 possible. In one study, however, proteinuria seemed to influ-
ence MAG3 clearance (= MAG3/hippurate clearance ratio). To inves-
tigate this, simultaneous MAG3 and hippurate clearance studies
(UxV/P) were performed in 9 patients with different degrees of protein.
uria and varying serum albumin levels. There was no significant linear
correlation between proteinuria and the MAG3/hippurate ratio (Y(ratio)
= 0.013X + 0.46; r = 0.43, P > 0.05). There was a significant linear
correlation between serum albumin level and the ratio (Y(ratio) =
—0,027X + 1.34, r =
—0.71, P < 0.05). This can be explained by the
relatively large protein binding of MAG3 compared to hippurate.
Despite the influence of serum albumin level on MAG3 clearance, there
was an excellent linear correlation between MAG3 and hippurate (Y =
0.59X —5.7, r = 0.98). After correction for the serum albumin level,
hippurate clearance values could be predicted from MAG3 clearance
values with a mean difference of 6% (range —7 to + 16%). We conclude
that proteinuria has no significant influence on MAG3 clearance. A low
serum albumin level seems to increase MAG3 clearance. After taking
account for this factor, MAG3 can be used to estimate ERPF.
Discrepancy between circadian rhythms of inulin (C1) and creatinine
clearance (Cr) In normal subjects. B.A.C. van Acker, G.C.M. Koomen,
M.G. Koopman, L. Arisz, Academic Medical Centre, Amsterdam, The
Net herland.c. Ccr usually overestimates glomerular filtration rate (GFR)
because of tubular secretion of Cr. Recently a circadian rhythm in GFR,
measured by C1,,, has been shown in normal individuals. But for Cr a
circadian rhythm is usually absent or not conspicuous. Tubular secre-
tion of Cr is postulated to be the cause of this difference. Therefore we
compared the circadian changes of C1,, and Cr in 12 normal individuals
during continuous infusion of In. Subjects kept at bedrest from 9 hours
(hrs) before first observation and had identical intake of food and fluid
every 3 hrs. Three-hour clearances were calculated for a period of 24
hrs and analyzed for circadian rhythm by cosinor analysis and a
variance ratio F-test. All 12 subjects had a circadian rhythm for C1,, with
orthophase (0, time of maximum) at midday (12.10 hr 50 mm, mean
scM) and relative amplitude (A/M, peak-trough value/mean x 100%)
of 21.5 2.6%. For Cr a circadian rhythm was absent in 9 and present
in 3 subjects (0: 13.20 hr 118 mm, A/M: 15.7 2.9%). The
contribution of tubular secretion to total Cci. was calculated by sub-
tracting C1,, from Car, and was lower at 0 of C1,, (10.3 2.3 mI/mm)
than at bathyphase (B, time of minimum) of C,,, (26.5 2.9 mI/mm). In
9 subjects a circadian rhythm for tubular secretion of Cr was present
with A/M of 120.0 16.6% and maximum at night (0 = 01.30 hr 63
mm). High secretion of Ccr during the night counteracts the normal
rhythm of GFR (= C10). We conclude that tubular Cr secretion has a
circadian rhythm with a phase opposite to the rhythm of GFR (= C,,,),
causing almost complete absence of a circadian rhythm for Cr.
Ontogeny of cyclic GMP production by atrial natriuretic peptide in
< 02 glomeruli microdissected from kidneys of young rats. B. Semmekrot, D.Cl,abardès, S. Rouseau, S. Siau,ne-Perez, L. Monnens andD. But/en,
<0 02 College de France, Paris, France and University of Njmegen, The
<002 Netherlands. Production of cyclic guanosyl-mono-phosphate (cGMP)
induced by alpha-rat atrial natriuretic peptide 1-28 (a-rAN?), carbamyl-
choline (CBC) and sodium nitroprusside (SNP) were measured in
isolated glomeruli microdissected from collagenase-treated kidneys of
2- to 34-day-old and adult rats. In both young and adult animals,
a-rANP-induced cGMP accumulation was proportional to the number
of glomeruli, and increased in a dose-dependent and saturable fashion
with increasing a-rANP concentrations (apparent activation constant
values: 6.4 nM and 9.7 nM for 5-day-old and adult rats, respectively).
Maximal doses of either a-rAN? or AN? 5-28 elicited similar responses
in young and adult animals. Clear differences emerged between the
ontogenetic patterns of cGMP accumulation stimulated by either
a-rAN?, CBC or SN?: the response to a-rANP was huge in the
youngest rats tested, dropped sharply during the suckling period and
12.0 8.4
11.8 14.5
16.8 8.8
27.0 8.3
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represented about 1.6-fold in the adult control level in 34-day-old rats;
in contrast, the response to CBC was low after birth and rose progres-
sively with age up to the adult level at the end of the weaning period,
while the response to SNP seemed to be independent of age.
Effects of calcium entry blockers on calcium influx in cultured opossum
kidney cells (OK). R.J.M. Bindels, R.J.J.M. Bakens and C.H. van Os,
Department of Physiology, University of N(jmegen, The Netherlands.
Ca2' uptake was measured in OK cells (cultured in Dulbecco's modi-
fied Eagle's medium supplemented with 5% FBS) at 37°C and proved to
be linear over 40 mm. In the presence of 2.5 ms LaCl3 no time-
dependent uptake could be demonstrated. Therefore, under these
conditions Ca2" influx in OK cells could be determined accurately and
averaged 21.7 0.3 pmol/min'mg protein. The effect of Ca2 entry
blockers on Ca2' uptake was then examined. D600, a verapamil analog
belonging to the phenylalkylamines; diltiazem, a benzothiazepine, and
fiunarizine, a diphenylpiperazine, inhibited Ca2 uptake in a dose-
dependent manner. D600 was the most effective inhibitor of Ca2
uptake (K = 45 ai), followed by diltiazem and flunarizine (both with
= 100 LM). In contrast, Ca2 entry blockers belonging to the
dihydropyridines, e.g. nifedipine and felodipine, had no effect on Ca2
uptake in OK cells. The dihydropyridines selectively block the voltage-
dependent Ca2 channels of the L-type in muscle and neuronal cells.
Presumably, OK cells possess functional Ca2 channels, however, with
an affinity several decades lower compared to excitable tissues. Prelim-
inary experiments with rat kidney membrane vesicles showed specific
binding of a verapamil analog, D888, preferentially to basolateral
membranes, with a KD —0.1 M, Therefore, it seems likely that Ca2
channels in OK cells are primarily located at the basolateral side.
Finally, the effect of PTH on Ca2 uptake in OK cells was investigated.
PTH induced in OK cells an increase in intracellular cAMP content as
well as a transient rise in intracellular Ca2 concentration. One micro-
mole of bPTH(l-84) decreased Ca2 uptake in OK cells by 31%. Ten
micromoles of forskolin also decreased Ca2 uptake by 51%, indicative
for cAMP being the second messenger involved in PTH action on Ca2
uptake in OK cells. In addition, the phorbol ester 12-0 tetradecano-
nylphorbol 13-acetate (TPA) decreased Ca2 uptake by 55%. Since
phorbol esters activate protein kinase C, this enzyme might also be
involved in the regulation of Ca2 channel activity in OK cells.
Aldosterone counteracts the changes in distal tubular function induced
by the calcium antagonist felodipine. H. W. van Hamersvelt, J.F.M.
Wetzels, H.J. Kloke, R.A.P. Koene, F.T/I.M. Huysmans, Department
of Medicine, Division of Nephrology, University of Nmegen, The
Netherlands. Dihydropyridine calcium antagonists such as felodipine
(F) induce an acute natriuresis without concomitant kaliuresis, suggesting
some direct or indirect effect on the distal renal tubule. The observed
decrease in plasma aldosterone concentration (PAC) despite increase in
PEA could be responsible for these distal tubular effects. We tested this in
a randomized, single blind, crossover study in 12 healthy male volunteers.
Exogenous aldosterone (A, total dose 0.26 mg) or placebo (P) was infused
for 200 mi superimposed on a 240 mm infusion of F (total dose 1.6 mg)
or P. A was started 40 mm after F. Blood pressure (Dinamap). RPF (PAH
clearance), GFR (inulin clearance) and fractional excretions of sodium
(FENa), potassium (FEK), and lithium (FELl) were measured before (basal)
and during drug infusions. Fractional proximal and distal sodium reabsorp-
tion (fPRNa and fDRNa) were calculated by I-FELl and lFENa/FEL,
respectively. A had no influence on the systemic and renal hemodynamic
effects of F. Mean values of electrolyte excretions and fractional sodium
reabsorption during the last 120 mm of combined infusions are given in the
table, with basal values as reference.
FENa % FEK % fPRN % fDRNa °1'
Basal 0.9 0.1° 16.5 l.la 76.0 0.9° 96.5 0.4
P + A 0.4 0.la 18.1 1.7' 75.7 0,8° 98.5 0.2°
F + A 1.5 0.2 23.2 1.3 65.9 1.9 95.8 0.4
F + P 2.4 0.4° 13.7 1.3° 68.3 1.8 92.3 1.1°
In conclusion, adding exogenous A to the infusion of F restores distal
tubular sodium reabsorption and induces kaliuresis, but does not
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completely inhibit natriuresis on F. This suggests that the decrease in
PAC is responsible for the distal tubular effects of calcium antagonists,
but that other mechanisms at a more proximal site must also be
involved in the natriuretic effects of these drugs.
Isolation and characterization of mouse glomerular basement mem-
brane. J.J. Baelde, K.J.M. Assmann, J.A. Brutjn, Department of
Pathology, University of Leiden, and Department of Pathology, Uni-
versity of N,jmegen, The Netherlands, Glomerular basement membrane
(GBM) antigens used for immunological studies have until now been
isolated from human and rat glomeruli but not from mice, because
isolation of relatively small mouse glomeruli by differential sieving and
centrifugation techniques is not feasible. However, given the growing
awareness of extracellular matrix species-specificity, the need for a
purification method of mouse GBM exists. We now report the purifi-
cation of GBM from isolated mouse glomeruli. Ten ml 0.01 M phosphate
buffered saline (PBS) containing 1.25% Fe304was perfused through the
aortae of (CS7BIIOxDBAI2)Fl mice over one minute, kidneys were
decapsulated and passed trough a 0.075 mm mesh metal screen and
collected. After pelletting and washing, the tube was placed against one
pole of a magnet and the pelleted glomeruli were washed. This
procedure was repeated three times. The glomerular suspension was
examined by light microscopy, sonicated, and lyophilized. In suspen-
sion no free fragments of tubuli or Bowman's capsule were present as
observed by light microscopy. Mouse GBM was prepared from the
isolated glomeruli using a modification of earlier described methods for
human and rat GBM by enzymatic digestion. ELISA studies showed
the presence of laminin, type IV collagen, and fibronectin. Monoclonal
antibody directed against tubular epithelial antigen gpl6o did not react
to either mouse or rat GBM and, as a positive control, did show binding
to mouse RTE. Sera and glomerular eluates from (C57BIIOxDBAI2)Fl
mice suffering from chronic graft-versus-host autoimmune disease gave
a higher signal against mouse GBM than against rat GBM. Normal
rabbit serum, normal mouse serum and normal mouse eluate did not
show significant activity against mouse GBM. Immunoblotting showed
the presence of both laminin B I and B2 chains as well as type IV collagen
al and a2 subunits. In sum, we describe for the first time a method by
which it is possible to extract mouse GBM with a high purity.
Murine chronic graft-versus-host disease: Further studies on the
nephritogenic role of autoantibodies directed against dipeptidyl peptidase
IV and laminin. J.A. Brwjn, E.H.G. van Leer, J.J. Baelde, W.E.
Corver, P.C. W. Hogendoorn, G.J. Fleuren, Department of Pathology,
University of Leiden, The Netherlands. We studied the pathogenesis of
renal involvement in murine chronic graft-versus-host disease (GvHD),
which is a model for human systemic lupus erythematosus. The disease
was induced in (C57BLIOxDBAI2)Fl hybrid mice by injection of
DBA/2 lymphocytes. The animals developed systemic disease with
deposition of auto-antibodies in the glomeruli, and a lupus type of
nephritis morphologically. We earlier reported the finding of antibodies
directed against renal tubular epithelial antigens (RTE) and against the
glomerular basement membrane (GBM) in sera and in whole-kidney
eluates of diseased animals. Antibodies were now eluted from glomeruli
which had been isolated at different stages of the disease by magnetic
extraction from iron-perfused kidneys. The specificity of the antibodies
was investigated using indirect immunofluorescence, enzyme-linked
immunosorbent assay (ELISA) and immunoblotting. In glomeruli from
week 4, autoantibodies were found to be directed specifically against
the GBM component laminin, and against the glomerular enzyme
dipeptidyl peptidase LV (DPP LV), while glomeruli from week 8 also
contained antibodies directed against nuclear antigens. Both laminin
and DPP LV are known nephritogenic antigens occurring in renal
tubular epithelial brush border preparations (RTE). Antibodies eluted
from isolated glomeruli of diseased animals bound in a granular pattern
along the glomerular capillary wall after in vivo transfer. Anti-RTE
antibodies were affinity-purified from the sera of diseased animals and
injected into naive mice. This led to the development of immune
complex glomerulonephritis and proteinuria, confirming the nephrito-
genic role of these autoantibodies in this model.
Dietary fish oil modifies renal function during early postoperative
rejection episodes in cyclosporin (CsA) treated renal allograft recipients.
J,J. Homan van derlleide, H.J.G. Bib, A.J.M. DonkerJ.M. Wilmink,
Means SEM; a P < 0.01 and b P < 0.05, compared to F + A
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W.J. Sluiter, A.M. Tegzess, Departments of Internal Medicine, Uni-
versity Hospital Groningen, Free University Hospital Amsterdam, and
University Hospital Amsterdam, The Netherlands. In a placebo-con-
trolled (6 g coconut oil, 63% C8:O and 36% Cl0:0), prospective,
randomized, double-blind study in acute postoperative cadaveric renal
allograft recipients, we investigated the effect of a daily supplementa-
tion of 6 grams fish oil (30% C20:5 omega-3 -EPA and 20% C22:6
omega-3) during one month on renal function. Twenty-nine patients
ingested placebo capsules (epa—) and 23 patients fish oil (epa+). There
were no differences in donor age, donor sex, total ischemic time, age,
sex, HLA pre-sentization and the number of mismatches on B and DR
loci. One month after grafting no differences in renal function were
observed, while the incidence of rejection episodes did not differ
significantly. Both groups were analyzed separately for rejection (re+)
and non-rejection (re—), creating 4 groups epa+re—, epa—re—,
epa+re+ and epa—re+.
epa+re—N=13 epa—re—N=23 epa+re+N=lO epa—re+N=6
CsAD mg/kg 6 6 6 5.5
CsAI ng/ml 235 180d l45 150
Scr pnol/literC ml/min/1.73
ni2
138
53
144
51
175
43
265b,c
26b.c
Sorea mmollliter 7.5 8.3 16 193b.c
MAP mm Hg 107 107 107 110
Median values, (ranges). Mann-Whitney U-test; a P<0.05 (epa+re+
vs. epa+re—); b P < 0.05 (epa—re+ vs. epa—re—); ° P < 0.05
(epa—re+ vs. epa+re+); d p < 0.05 (epa—re— vs. epa+re—). CsAD =
CsA dose; CsAI = CsA whole blood level.
Conclusions: 1) In renal allograft recipients dietary supplements with
fish oil have a significant beneficial impact on renal function during or
shortly after an early rejection episode. 2) After one month of fish oil
supplementation there is no difference in renal function between the
non rejecting fish- and corn oil-treated -CsA-treated allograft recipients,
despite higher CsAl in the epa+re— group. 3) Both the epa+ and epa—
groups had significantly lower CsAI in case of rejection.
Dietary fatty acids and kidney transplantation in the rat. W.J. Korl,
M.H. de Kejzer, f.M. Hekking-WeUma, M. Verme,j, Laborato,y for
Experimental Surgery, Department of Pediatric Surgery and Depart-
ment of Pathological Anatomy, Erasmus University, Rotterdam, The
Netherlands. Immunological changes induced by dietary polyunsatu-
rated fatty acids (PUFA) such as linoleic acid are common knowledge.
The negative influences of such immunosuppression on health and in
particular on cancer have been highlighted. However, possible positive
effects of dietary induced immunosuppression have not been given
much attention. As such it is conceivable that special diets would prove
to be helpful in the prevention of chronic kidney graft rejection. Also,
certain PUFA's are able to inhibit platelet aggregation and by these
means to prevent the damage associated by chronic rejection to the
capillary vessel system of the transplant organ. As linoleic acid and
some PUFA's found in fish oil are ascribed to have the potency to
prevent platelet aggregation, it is a tempting hypothesis that by modu-
lating the PUFA content of the diet immunosuppression as well as
inhibition of platelet aggregation is achieved improving kidney graft
survival. To test this hypothesis in 5 groups of 15 rats allogenic kidney
transplantations were performed. Four groups received pre- and post-
operatively a semisynthetic diet, isocalorically but differing in quantity
and quality of fatty acids. Group I received a diet high in saturated fat,
Group II a diet high in linoleic acid, Group Ill a diet containing fish oil,
and Group IV a diet high in monoenoic acid. Finally, a fifth group of rats
received a standard commercial chow and served as a control for the
procedure of technique and immunological regimen. All groups re-
ceived the same immunosuppressive regimen of immunological en-
hancement induced by pretreatment with complete donor blood. Sur-
vival and several parameters of kidney function were studied. The
results showed that the technical mortality, i.e. animals dying in the first
week of transplantation, was substantially higher in rats fed semisyn-
thetic diets in comparison with the group of rats fed commercial diet. A
significant better renal function could be observed in the group of rats
on the diet high in linoleic acid in the first period after kidney
transplantation. These differences disappeared in the course of the
study when a number of animals was lost due to graft rejection. In this
diet group mortality due to rejection was significantly decreased as well.
We conclude that a diet high in linoleic acid improves kidney graft
survival in rats.
Erythremia (E) after kidney transplantation. R.M. Huisman, R.
Engelsma, H.J. Brus, W.J. van Son, A.M. Tegzess, University Hospi-
tal, Groningen, The Netherlands. Since we had the impression that in
our institution the number of therapeutic venesections was increasing in
recent years we retrospectively analyzed all kidney transplantations
done in our hospital for the occurrence of E, defined as hematocrit over
50% on two or more consecutive occasions. Recent transplants (fol-
low-up less than 1 year) were excluded from the analysis as well as
those with primary non-function. During the period of conventional
immunosuppression (azathioprine + prednisolone) from 1968 to 1983
(period I), 359 kidney transplantations took place and E developed in 30
cases (8.4%). During the period of cyclosporine treatment (nearly
always combined with prednisolone; period H) up to 1988 318 trans-
plantations resulted in 53 cases of E (16.7%). The difference in
frequency of E was highly significant (P < 0.005, chi-square test). In
period lIthe E was not only more frequent but it also started earlier:
median time of onset in period I was 17 months after transplantation, in
period H this was 9 months (P < 0.005, 1-test). In nearly all cases in both
periods the disorder was self-limited and the duration was also similar;
in both periods approximately half the episodes lasted less than 6
months. The characteristics of patients with E were also similar in both
periods. It developed more often in men than in women (10% of the
men, 4% of the women during period I, P < 0.05; 20% of the men, 12%
of the women in period II, P = 0.06). Transplantations after which E
developed had younger donors than those without E (median age 22 vs.
25 years in period I, 26 vs. 32 years in period II, P < 0.05 in both
periods). There were no significant differences in original kidney
disease between those that developed E and those that did not.
Thromboembolic complications were relatively rare. Of all patients
with E only 3 developed documented venous thrombosis, 5 had
pulmonary embolism and 1 had a cerebral vascular thrombosis. In
conclusion, E does occur more often when cyclosporine is used in
kidney transplantation, but it carries a relatively low risk.
Immediate hemodynamic effects of cyclosporine infusion on human
kidney grafts detected by Doppler spectrum analysis. J.W.S. Merkus,
W.N.J.C. van Asten, A.J. Hoitsma, S.H. Skotnicki, R.A.P. Koene,
Clinical Vascular Laboratory and Department of Nephrology, Univer-
sity Hospital Njjmegen, The Netherlands. The nephrotoxicity of cy-
closporine (CsA) is at least partly caused by its vasocontrictive action.
The aim of this study was to determine whether Doppler spectrum
analysis can detect immediate hemodynamic changes in the trans-
planted kidney after CsA infusion. Seventy-five duplex examinations
(Toshiba SSA27O-A) were performed in 15 recipients. During each
examination spectra of the renal artery at the hilus of the allograft and
at the interlobar arteries were obtained. CsA infusion was started six
hours after opening of the vascular anastomosis. The first examination
was performed half an hour before, and subsequent examinations were
done one and four hours after the start of the infusion. On days one and
two after transplantation duplex examinations were repeated. Doppler
spectra were stored for off-line computer analysis. Several parameters
of the spectra were statistically analyzed. After the start of the CsA
infusion the spectrum waveform altered significantly. Parameters indi-
cated increased vascular resistance. Especially Tmax, the time period
between the beginning of the spectrum waveform and the maximal
frequency, decreased significantly (106 58 ms vs. 76 36 ms; P <
0.05). On days one and two after transplantation the spectrum wave-
form returned to its original shape. Irrespective of the Resistance Index
(RI) in the first measurement the RI values were below 0.67 on day two.
Tmax increased again from 76 36 ms to 117 57 ms (P < 0.05). These
data indicate that infusion of CsA has an acute and temporary effect on
the vascular resistance of the renal allograft. These hemodynamic
effects can be measured by Doppler spectrum analysis. Therefore this
method might be suitable to determine whether comparable changes
will occur during periods of overt CsA nephrotoxicity.
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HLA match of blood donor and recipient and the formation of T and B
cell antibodies. J.P. van Hooff, P.M. van den Berg-Loonen, University
Hospital Maastricht, The Netherlands. It has been shown that patients
transfused with one single unit of blood mismatched for both HLA Dr
antigens have an increased rate of formation of leucocyte antibodies,
compared to patients who received blood which differs for only one Dr
antigen. These data were collected partly retrospectively and the
number of patients was small. Furthermore, no information was avail.
able whether these antibodies were directed against T or B cells.
Therefore, a study was started about the influence of HLA match of
recipient and blood donor on the formation of T and B cell antibodies.
One single blood transfusion was given to renal patients who neither
had received before a blood transfusion nor had been pregnant. After
transfusion HLA antigens of the donor was determined. After one, two
and four weeks blood samples were tested for the presence of T cell, B
cell, auto-T and auto-B cell antibodies. Furthermore, cross matches
were done with T and B cells of the blood donor. So far, the data of 108
transfusions have been analyzed. Nine patients received blood with no
HLA/Dr mismatches, 45 with one Dr and 54 with two mismatches.
These groups did not differ significantly for mismatches of HLA A+B
antigens. None of the patients who received Dr compatible blood
formed T cell antibodies. The percentage of patients, who formed T cell
antibodies after transfusion with one or two Dr mismatched blood, was
respectively 6 and 0%. There was no significant influence of Dr match
of patient and blood donor on the formation of B cell antibodies. The
percentages were II, 40 and 26 for 0, I, 2 Dr mismatches, respectively.
Conclusion: After one single blood transfusion T cell antibodies are
formed rarely, while B cell antibodies can be frequently detected. No
relationship was present between HLA match of blood donor and
recipient and the formation of I and/or B cell antibodies.
Immunocytology of urinary sediments in renal transplant patients with
deteriorating graft function. P/LM.M. Dooper, M.J.J.T. Bogman, C.N.
Maass, G.P. Vooys, R.A.P. Koene, Depart,nents of Pathology and
Medicine, Division of Nephrology, University Hospital N:jmegen. The
Netherlands. Previously we have shown that increase in HLA-DR
expression on tubular epithelial cells (TEC) and T lymphocytosis, as
observed in renal biopsies and fine needle aspirates of renal transplant
recipients with acute rejection (AR), is also reflected in the cells
appearing in the urine. In the current study we examined urinary
sediments of 98 patients, with deteriorating transplant function by
different causes, to determine whether immunocytologic analysis can
be used to differentiate AR from other causes of declining graft
function. Cytocentrifuge preparations of fresh urinary sediments were
incubated with monoclonal antisera against T cell markers (T II,
UCHL I) and HLA-DR antigen, followed by incubation with alkaline
phosphatase-conjugated rabbit anti-mouse Ig and color development
with Fast Red TR. Sections were studied without knowledge of the
clinical data. The presence of both T lymphocytosis and increased
HLA-DR positivity of TEC was considered to indicate AR. Twenty-
four specimens were inadequate for analysis (24%). Of 44 sediments
with immunocytologic signs of AR, 38 correlated with a clinical and/or
histologic diagnosis of AR; six were falsely positive. In 30 sediments no
signs of AR were found. In three of these the results were false
negative. In this study the sensitivity of the immunocytologic diagnosis
was 93%, the specificity 82%. The predictive value of a positive result
was 86%. We conclude that immunocytological examination of the
urinary sediment is a useful and simple adjunct in discriminating AR
from other causes of renal graft dysfunction.
Prostaglandins (PG's) do not mediate the natriuresis of head.out water
immersion (HOl) in humans. A.J. Rabelink, H.A. Koomans. E.J.
Dorhout Mees. Department of Nephrology, University Hospital
Utrecht, Utrecht, The Netherlands. Studies in the past have shown that
acute administration of the PG synthesis inhibitor indomethacin (I)
decreases the natriuretic response to HO!, particularly during sodium
restriction. However, in this sodium restricted situation the acute
sodium (Na) retaining effect of indomethacin counteracted the natri-
uretic effect of HO!, which makes it impossible to judge the role of PG's
in HOL-induced natriuresis. To solve this problem we designed a study
to compare the effect of acute and chronic use of indomethacin on the
natriuretic response to HO!, during low (40 mmol) as well as high (200
mmol) Na diet in six healthy subjects. During either diet HOl effects
were studied on 3 occasions: control, and after acute (I day) and
chronic (13 days) use of indomethacin. HOI was performed during
water loading and clearance conditions. Results: During the 40 mmol
Na diet HO! increased sodium excretion (UNaV) from 33 9 to 179
39 smol/min. After acute and chronic administration of indomethacin
these figures were: 16 9 to 81 36 (acute I) and from 37 12 to 163
36 (chronic 1) mol/min. During the 200 mmol Na diet, HO! increased
UNV from 164 20 to 315 60 smol/min. After acute and chronic
administration of indomethacin UNaV rose during HOI from 176 40 to
342 97 (acute I) and from 203 52 to 322 57 (chronic I) mol/min.
Thus, although during low sodium diet indomethacin reduced UNaV
prior to and during HO!. it did not reduce the increase in UNaV caused
by HOl (delta 535%during control HO! vs. 510% during acute I-HO!).
In all other conditions 1JV did not differ from control studies. HOt
increased fractional excretion of lithium and free water excretion.
Indomethacin had opposite effects on these parameters, but could not
prevent the increase caused by HO!. HO! increased estimated renal
plasma flow (ERPF) and decreased filtration fraction. These effects
were prevented by indomethacin in each of the conditions studied.
These data suggest that although inhibition of PG synthesis causes
sodium retention, PG's play no immediate role in the natriuretic
response to HO!. Furthermore, the increase in ERPF observed during
HO! is not essential for the subsequent natriuresis.
Do beta.2 receptors contribute to renin release in man? P. W. de
Leeuw. P.N. van Es. PT. Tchang, Department of Medicine, Zuider-
ziekenhuis, Rotterdam. The Netherlands. Although the role of beta-I
adrenoceptors in regulating renal renin release is beyond dispute, little
is known about the potential influence of beta-2 adrenoceptors in man.
To explore whether beta-2 adrenoceptors can modify renin secretion,
we infused saline (group 1; N = 8), atenolol (group II; N = 8) or
propranolol (group III; N = 7) into the renal artery of hypertensive
patients just before diagnostic renal angiography. The atenolol and
propranolol were infused at a fixed rate at the maximal dose that can be
administered without producing systemic effects. Blood for assay of
noradrenaline and active renin was drawn simultaneously from the
renal artery and vein before and 15 minutes after the start of each
infusion. At the same time renal blood flow was measured by xenon
washout. Subsequently, on top of these infusions, isoprenaline was
administered for 15 minutes at a dose which would not produce
systemic effects (I ng/kg per mm). At the end of this second infusion
renal flow, renin and noradrenaline were measured again. The results
show that isoprenaline alone (group!) increased renin secretion (veno-
arterial differences times flow) by 188 43%. In group II renin
secretion rose by 110 56%, but in group 111 by only 5 12%.
Compared with group!, renin release was significantly reduced by both
atenolol (P < 0.05) and by propranolol (P < 0.01). Similar data were
obtained for noradrenaline 'release' from the kidney. Thus, selective
blockade of beta-I adrenoceptors in the kidney does not effectively
reduce renin (and noradrenaline) secretion as non-selective beta block-
ade does. This may indicate that beta-2 adrenoceptors are also involved
in regulating renin release. Perhaps these receptors are located presyn-
aptically.
Disease actis'ity of SLE during dialysis and after renal transplantation.
J.C. Nossent, A.J.G. Si'aak, J.H.M. Berden on behalf of the Dutch
Working Party on SLE. Daniel den Hoed Clinic, Rotterdam and
University Hospital Nijmegen, N,jmegen, The Netherlands. We have
retrospectively evaluated the disease activity in SLE patients before
and after the initiation of dialysis treatment (N = 55) and after renal
transplantation (N = 28). Furthermore, SLE disease activity was
compared for patients treated with either hemodialysis (HD) (N = 32)
or CAPD (N = 23). SLE patients receiving renal replacement therapy
on March 1. 1988 were identified with the help of the central registration
for renal replacement therapy in the Netherlands, RENINE. Disease
course was investigated maximally 4 years before and after the start of
dialysis, and after transplantation. Disease activity per patient was
recorded at 3 month intervals with the use of the validated SLE disease
activity index (SLEDA!). Actuarial patient survival on dialysis was
94% at 12 months and 89% at 60 months; there was no difference in
survival between HD or CAPD treated patients. The mean (± SD)
maximal non.renal SLEDA! was significantly higher (P < 0.01) before
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dialysis (8.2 6.3) than during dialysis (4.4 5.9). The percentage of
patients with a high non-renal SLE disease activity (non-renal SLEDAI
> 10) decreased significantly (P < 0.01) after the start of dialysis
treatment (before 30.9 and during dialysis 14.6%), while the percentage
of patients with absence of non-renal disease symptoms (non-renal
SLEDAL = 0) increased significantly during dialysis (3.6% vs. 34.5%).
No differences were observed in maximal non-renal SLEDAI between
HD and CAPD-treated SLE patients. Of these SLE patients 28 under-
went renal transplantation. In these patients, the mean (± SD) maximal
non-renal SLEDAI before dialysis (15.8 7.4) showed also a significant
decrease during dialysis (3.7 5.6), which diminished further after
transplantation (1.2 3.8). Also the percentage of patients with high
non-renal SLE disease activity (non-renal SLEDA! > 10) decreased
from 60% before dialysis to 11% during dialysis and became 0% after
transplantation. This study, at present the largest in the literature,
indicates that SLE patients are excellent candidates for renal replace-
ment therapy. During dialysis non-renal SLE disease activity decreases
significantly, No differences are observed in SLE disease activity
during HD or CAPD treatment. After renal transplantation non-renal
SLE disease activity decreases even further.
